<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE"><gtr:id>E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE</gtr:id><gtr:name>Gene Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE"><gtr:id>E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE</gtr:id><gtr:name>Gene Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/60B70014-0DA9-42DD-834E-9D5622E53D24"><gtr:id>60B70014-0DA9-42DD-834E-9D5622E53D24</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Benjamin</gtr:otherNames><gtr:surname>Ascher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9387F657-B9DB-4164-B995-7D2147B97EC5"><gtr:id>9387F657-B9DB-4164-B995-7D2147B97EC5</gtr:id><gtr:firstName>Sharon</gtr:firstName><gtr:surname>Peacock</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/877C0FAD-13BC-4F15-A199-F32B4E46D637"><gtr:id>877C0FAD-13BC-4F15-A199-F32B4E46D637</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Blundell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM026302%2F1"><gtr:id>17A20E3E-D91B-4EDE-A2EF-DD050538FB9C</gtr:id><gtr:title>Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M026302/1</gtr:grantReference><gtr:abstractText>Tuberculosis is recognised as one of Brazil's leading infectious diseases, with over 70,000 cases notified each year. There has been a significant increase in the number of diagnosed Multidrug resistant TB cases, with 10% of those also resistant to the two most important second---line class drugs (XDR-TB). This project aims to build upon existing collaborative programs on understanding effects of mutations, and on combating multidrug resistant and extensively drug resistant (MDR and XDR respectively) tuberculosis (TB). The two nodes, Brazil and UK, have complementary skills that encompass epidemiology, human and pathogen genetics, bioinformatics, structural biology and drug discovery. This multidisciplinary combination will facilitate the development of a novel platform to rapidly identify resistant TB from genomic sequencing. Novel mechanisms of drug resistance in TB will be explored using cutting edge techniques and correlated with clinical outcomes. This will help guide more suitable patient treatment, public health policies and future drug discovery efforts, with potential to bring benefit to individuals and public health in Brazil and UK, providing solutions to a problem that affects a third of the world's population.</gtr:abstractText><gtr:technicalSummary>Tuberculosis is recognised as one of Brazil's leading infectious diseases, with over 70,000 cases notified each year. There has been a significant increase in the number of diagnosed MDR-TB cases, with 10% of those also resistant to the two most important second-line class drugs (XDR-TB). In line with WHO Stop TB Strategy, our partnership will focus on emerging sequence-based diagnostics to improve accuracy of individual patient treatment. This project aims to build upon existing collaborative programs on understanding effects of mutations, and on combating multidrug resistant and extensively drug resistant (MDR and XDR respectively) tuberculosis (TB). The two nodes, Brazil and UK, have complementary skills that encompass epidemiology, human and pathogen genetics, bioinformatics, structural biology and drug discovery. This multidisciplinary combination will facilitate the development of a novel platform to rapidly identify resistant TB from genomic sequencing. Novel mechanisms of drug resistance in TB will be explored using cutting edge techniques and correlated with clinical outcomes. This will help guide more suitable patient treatment, public health policies and future drug discovery efforts, with potential to bring benefit to individuals and public health in Brazil and UK, providing solutions to a problem that affects a third of the world's population.

Specific aims:
i)Enhance an existing research partnership, bringing equitable scientific and health benefits to Brazil and the UK.
ii)Develop a novel and effective platform to identify drug-resistant TB.
iii)Facilitate training and knowledge transfer, enhancing independent research capacity and fostering international collaborative projects.</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2016-01-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-01-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>49396</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>65BE2C95-3D77-4325-BD83-D0362E73534E</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-5</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gene Laboratory</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Laborat&amp;oacute;rio Gene</gtr:description><gtr:id>AC54BA1F-86A8-46B3-90B1-2AD50F904FE6</gtr:id><gtr:impact>This is multi-disciplinary- involving clinicians, geneticists, bioinformaticians and experimentalists.

To date one paper has been submitted.</gtr:impact><gtr:outcomeId>56d85d7d7ef989.56047353-1</gtr:outcomeId><gtr:partnerContribution>Identification of novel genetic mutations and validation of our predictions.</gtr:partnerContribution><gtr:piContribution>Analysing genetic mutations identified by Professor Sergio Pena and his team.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life Sciences</gtr:department><gtr:description>Shorten-TB</gtr:description><gtr:id>5228B5AD-F3E5-4E0B-9B69-C3A225B6DA58</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bfbdb935c655.92496896-1</gtr:outcomeId><gtr:partnerContribution>Drug screening and development</gtr:partnerContribution><gtr:piContribution>Analysis of structure, function and druggability of targets in tuberculosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Groningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>2095C1E0-A71B-43DF-AAF3-48C96C924265</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-6</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Institute of Infectious Disease and Molecular Medicine (IIDMM)</gtr:department><gtr:description>Shorten-TB</gtr:description><gtr:id>8B14DF9C-04E2-4E49-910E-05B49429E72C</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bfbdb935c655.92496896-3</gtr:outcomeId><gtr:partnerContribution>Drug screening and development</gtr:partnerContribution><gtr:piContribution>Analysis of structure, function and druggability of targets in tuberculosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life Sciences</gtr:department><gtr:description>Identifying targets from phenotypic screening in tuberculosis</gtr:description><gtr:id>8040E7D7-8844-4157-9ED1-1986EE1535C5</gtr:id><gtr:impact>Talks in meetings identified elsewhere by various participants. Discussions with HIT-TB Consortium</gtr:impact><gtr:outcomeId>58bfbabfbee5d9.82144568-1</gtr:outcomeId><gtr:partnerContribution>Dundee has contributed software and expertise in medicinal chemistry</gtr:partnerContribution><gtr:piContribution>Collaboration Funded by Gates Foundation to identification of new targets for drug discovery arising from phenotypic screens. My team has contributed knowledge, databases and software focusing on protein targets in Mycobacterium tuberculosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Shorten-TB</gtr:description><gtr:id>9D706436-C4C2-4C10-AAC2-67D688E75ED5</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bfbdb935c655.92496896-2</gtr:outcomeId><gtr:partnerContribution>Drug screening and development</gtr:partnerContribution><gtr:piContribution>Analysis of structure, function and druggability of targets in tuberculosis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>91FD1012-4636-464A-ABB1-902B2852AC47</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-3</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>7EC18048-E183-450C-A185-76DBE9168517</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-2</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>79775559-397E-40C8-8C50-AA33A96ECC27</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-4</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>5D3CF45C-42E0-44B8-9C7F-D1A3897C38BD</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:outcomeId>BSiDRU7Hp1N-1</gtr:outcomeId><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BIOINFORM?TICA ESTRUTURAL DE PROTE?NAS: MODELOS, ALGORITMOS E APLICA??ES BIOTECNOL?GICAS, Belo Horizonte, Brasil</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA676003-E562-4A12-91D4-CF072221FEC8</gtr:id><gtr:impact>A joint Brazil-UK workshop bringing together discussion human genetics and race in Brazil with our analyses of the effects of genome mutations on genetic disease, cancer and antimicrobial resistance</gtr:impact><gtr:outcomeId>56d845f737dd17.28115858</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Sanger Institute Genomics for Clinicians course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>498D3D88-D58A-454D-AC61-B68C67A49675</gtr:id><gtr:impact>A talk on pathogen genomics to clinical professionals attending a 1 week course to gain an understanding of the application of genomics to clinical practice</gtr:impact><gtr:outcomeId>589722fe6aa744.12959400</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science festival event (2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1077B8CD-9CFB-46A6-8220-F10E0FEAEC78</gtr:id><gtr:impact>Sharon Peacock organised for the actor Stephen McGann to give a presentation as part of the Cambridge Science Festival 2015 entitled: 'Infectious knowledge:science in popular culture'
He is a keen science communicator and spoke about the power of science and its place at the heart of public conversation. There was a good discussion between presenter and audience at the end. 
Feedback gathered at the end of the talk was generally very positive:
This event was really well suited to an audience of teens and could have been marketed as such.
Absolutely brilliant, interesting lecture! 
Really enjoyed this event.
Infectious Knowledge: I was disappointed in the simplistic approach to science, but that's popular culture.</gtr:impact><gtr:outcomeId>56a8e6da33a249.84845829</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/system/files/csf_2015_web_programme.pdf</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Indian National Science Congress 2016, Mysore</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5874C730-94B9-4006-9242-9C26F6E40272</gtr:id><gtr:impact>General theme: Science &amp;amp; Technology for Indigenous Development in India. Tom Blundell Plenary Lecturer on Drug discovery for infectious disease in India where budgets have to be low. Open Source Drug Discovery, Biotech Spin-outs and Academia in Research Ecosystems</gtr:impact><gtr:outcomeId>56d848d0b468c4.20351136</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.isc103.in</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Therapeutics Forum: Pharma, Biotech, Clinical School and University</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D12D3C86-C92F-4014-BA5F-A3C5AB6AC621</gtr:id><gtr:impact>A short presentation by Tom Blundell to a mixed group involved in research ecosystems. Exemplified by foundation of Astex in my lab, progression to science park, candidate drugs into man, phase III, sale for $886million.

The second talk given by Sir Greg Winter,</gtr:impact><gtr:outcomeId>56d84ae4bce6b8.75683486</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.onenucleus.com/cambridge-new-therapeutics-forum</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tom Blundell appointed 8th Distinguished Technopreneur  2015, Singapore</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7A65E449-983D-45D0-B47E-5A6FCD28755A</gtr:id><gtr:impact>A discussion by Tom Blundell of research ecosystems, based on experience of forming companies in London and Cambridge, and looking at options for Singapore.

Discussions with Deputy Prime Minister of Singapore; visit of Head of Research to my company on the Science Park</gtr:impact><gtr:outcomeId>56d84c711e7dd9.14859407</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.science50.com.sg/dts.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit by Tom Blundell (Suffolk)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>605C0CF8-6FCF-45E6-B33A-F3198739FAF3</gtr:id><gtr:impact>Talk and opening a plaque to Dorothy Hodgkin commemorating her attendance at a secondary school in Beccles. Designed to encourage young students to do science - with local MP and relatives of Dorothy. Extensive media coverage in local papers.</gtr:impact><gtr:outcomeId>56dda0c7715055.55244152</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Weaver Endowed Lecture at UC Davis California</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3B0DCCC5-F0DF-48CD-BAA8-19ABF5FDD868</gtr:id><gtr:impact>A general lecture to a broad audience about the contributions of my science to drug discovery over the past 50 years</gtr:impact><gtr:outcomeId>58bc49f6ce3158.17006726</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Two lectures in University Pretoria, first to broad audience of students, policy makers, teachers; the second to students from the local Ndebele township</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6D04C06F-636B-48EB-8936-6D70E04EEBE5</gtr:id><gtr:impact>Lectures leading to small discussions with groups of mainly Ndebele speaking undergraduate students; followed by visit to local township for discussions mediated by Dr Gugu Motshwene, and ex-tudent now lecturer in the University of Pretoria</gtr:impact><gtr:outcomeId>58bc4c5aa6f6e2.53393913</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Antimicrobial Resistance Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>017FCED3-2EC0-4C75-BCFB-455A7CA2ABFF</gtr:id><gtr:impact>Workshop discussing with policy makers, clinicians, scientists and research students in order to understand and cobalt impacts of antimicrobial resistance, mainly in tuberculosis</gtr:impact><gtr:outcomeId>58bfc5c41fb786.31150298</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B82DF9EE-C911-4CEB-AFE8-AB27394A2F4C</gtr:id><gtr:outcomeId>56cd9d6ee097c2.71849156</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1588479</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC antimicrobial resistance collaboration</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C576CB61-F97C-4C00-ADC9-74A1F7D868CC</gtr:id><gtr:outcomeId>56cda1629a6898.11018544</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11999339</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>UK Rapid Support Team</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>244DE740-1C94-460B-83A4-879F178953D1</gtr:id><gtr:outcomeId>56cd9973b093a8.17682486</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>87D8B2B2-C8A4-4C4C-9071-202D703385EF</gtr:id><gtr:outcomeId>56cd9c3a9c6673.49506017</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton Researcher Links Workshop Grants</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>216419211</gtr:fundingRef><gtr:id>73E08D7C-8CC2-47D0-8EB2-993F46494739</gtr:id><gtr:outcomeId>56d84321766b89.13794281</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1007929</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge-Chennai centre partnership on antimicrobial resistant tuberculosis</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>212B284A-5CBD-42D2-8F16-50EE4D90170D</gtr:id><gtr:outcomeId>569d1a581492f4.14850003</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1159686</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton Fund MRC-UK DBT-India</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>RG77600, Project: RCAG/623</gtr:fundingRef><gtr:id>0DBD85EC-F1FD-45D7-8113-55E511D8D8A4</gtr:id><gtr:outcomeId>56bd995ee36e35.76092451</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A database of protein interactions, including protein-protein, protein ligand</gtr:description><gtr:id>5E6CC7D9-9E9C-40A5-9C5A-0AA0BE6D4A9E</gtr:id><gtr:impact>Used to understand drug interactions with protein targets</gtr:impact><gtr:outcomeId>56d857390b39f8.69581085</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Credo</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://marid.bioc.cam.ac.uk/credo</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>pkCSM is a novel, freely available method for predicting the pharmacokinetics and toxicity of small molecules- major limiting factors in drug development.</gtr:description><gtr:id>96E00DAD-3BB2-45A7-A098-DC738753ADAF</gtr:id><gtr:impact>The server has been reviewed in a commentary in Science Translational Medicine, and is currently receiving over 7000 hits/month from academic and pharmaceutical sites around the world.</gtr:impact><gtr:outcomeId>56d85f6185bf12.73145142</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pkCSM</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/pkcsm/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Database of the structural proteome of Mycobacterium tuberculosis</gtr:description><gtr:id>995F0FFD-7726-46A7-BCAC-2B873989B810</gtr:id><gtr:impact>Helpful in understanding the druggability of targets for antibacterials for tuberculosis</gtr:impact><gtr:outcomeId>58bfc73705df14.59859362</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Chopin</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://mordred.bioc.cam.ac.uk/chopin/about</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A machine learning approach to understanding the mechanisms by which mutations affect human genetic disease, drug resistance in cancer and antimicrobial resistance in human and infectious disease</gtr:description><gtr:id>1B5F188F-59FE-423E-975F-A6D8FFDA21B0</gtr:id><gtr:impact>Demonstration that both genetic disease and drug resistance mechanisms include allosteric and protein interface affects, leading to suggestions about novel therapeutic mechanisms.</gtr:impact><gtr:outcomeId>56d855fdb7d1b8.29535329</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mCSM and mCSMlig</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/mcsm/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>An updated webserver for the improved SDM, used for predicting the effects of mutations on protein stability. We have updated the environment-specific amino-acid substitution tables based on the current expanded PDB (a 5 fold increases in information), and introduced new residue conformations and interaction parameters, including packing density and residue depth.</gtr:description><gtr:id>8FFE0F6F-D238-4BBC-A5E3-3D0BD27B26DF</gtr:id><gtr:impact>The updated server has been extensively tested using a wide benchmark containing 2690 point mutations from 132 different protein structures. Using an established benchmark, the revised method correlated well against the hypothetical reverse mutations, better than comparable methods built using machine-learning approaches, highlighting the strength of our knowledge-based approach for identifying stabilising mutations. Given a PDB file (a Protein Data Bank file format containing the three-dimensional coordinates of the protein atoms), and a point mutation, the server calculates the stability difference score between the wildtype and mutant protein.</gtr:impact><gtr:outcomeId>58bfecd7939e54.50810441</gtr:outcomeId><gtr:title>sdm</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://structure.bioc.cam.ac.uk/sdm2</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Machine learning approach to predicting the impacts of mutations on protein stability and interactions with other proteins, nucleic acids, and small molecule ligands.</gtr:description><gtr:id>4345B38D-7574-4BB6-8BC2-43D520A9C840</gtr:id><gtr:impact>It has significant impact on understanding mutations in genetic disease and drug resistance</gtr:impact><gtr:outcomeId>58bfedcd2fade5.17980243</gtr:outcomeId><gtr:title>mCSM</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/mcsm/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>027DA821-13DF-4177-8FAA-963CFDA34BED</gtr:id><gtr:title>Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2740deeccb57d942289f664e528efd0"><gtr:id>a2740deeccb57d942289f664e528efd0</gtr:id><gtr:otherNames>Pandurangan AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5a97ecb0213b07.71767293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E87E870C-243B-4BDC-920B-818D33963F1A</gtr:id><gtr:title>Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design.</gtr:title><gtr:parentPublicationTitle>Expert opinion on drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c3960b875a6e75eb5068b1c9dd6eb2a"><gtr:id>8c3960b875a6e75eb5068b1c9dd6eb2a</gtr:id><gtr:otherNames>Albanaz ATS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1746-0441</gtr:issn><gtr:outcomeId>5a2fd22401ece5.76019254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F991FD8E-B9BF-4800-ACB7-1953F0AE30D9</gtr:id><gtr:title>In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56c9ca3b3b4372.69812248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7B2264F-0194-43A0-B0EC-301922EB29F9</gtr:id><gtr:title>Ubiquitin-Dependent Modification of Skeletal Muscle by the Parasitic Nematode, Trichinella spiralis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e96854e6178e0974d5128fda0de195f4"><gtr:id>e96854e6178e0974d5128fda0de195f4</gtr:id><gtr:otherNames>White RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>588b6ab9412598.18632617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5588A5D-E91D-4BD4-AA08-8E84CE7E3BE6</gtr:id><gtr:title>Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry.</gtr:title><gtr:parentPublicationTitle>IUCrJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23cc3f9657a8d5d3e2fc11b3f13944b6"><gtr:id>23cc3f9657a8d5d3e2fc11b3f13944b6</gtr:id><gtr:otherNames>Blundell TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2052-2525</gtr:issn><gtr:outcomeId>5a97ecaf2b91f7.49782651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3EA77D6-5C3A-4280-8658-DFDA8A5ABE84</gtr:id><gtr:title>Flexibility and small pockets at protein-protein interfaces: New insights into druggability.</gtr:title><gtr:parentPublicationTitle>Progress in biophysics and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2dfe990ea4c3b7049f41e47d392f389"><gtr:id>f2dfe990ea4c3b7049f41e47d392f389</gtr:id><gtr:otherNames>Jubb H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0079-6107</gtr:issn><gtr:outcomeId>56c9d1da4c1e44.65318475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5316316-1AF7-4C7B-BD9A-DD1CD5279CF6</gtr:id><gtr:title>Target Identification ofPhenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee541eb088247fffcc18ca504f34be6"><gtr:id>bee541eb088247fffcc18ca504f34be6</gtr:id><gtr:otherNames>Mugumbate G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>5a97ebdbd4e2d4.53955385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11FD3BE2-2423-4EC8-86C9-30CB48A6E20A</gtr:id><gtr:title>Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0338972eb64b2c9188c2e8617d57c46"><gtr:id>e0338972eb64b2c9188c2e8617d57c46</gtr:id><gtr:otherNames>Jubb HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>58bc5648a186d3.48476431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03484F5C-26AD-409B-935E-B2CC5DB79DE2</gtr:id><gtr:title>Mutations at protein-protein interfaces: Small changes over big surfaces have large impacts on human health.</gtr:title><gtr:parentPublicationTitle>Progress in biophysics and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0338972eb64b2c9188c2e8617d57c46"><gtr:id>e0338972eb64b2c9188c2e8617d57c46</gtr:id><gtr:otherNames>Jubb HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0079-6107</gtr:issn><gtr:outcomeId>588b6ab65b6872.34338634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02C26FD0-F234-4088-A084-CA46BECC816E</gtr:id><gtr:title>mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>585d74278d8523.96948027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9E65739-4571-4489-80FE-F4C59093DC7A</gtr:id><gtr:title>mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d74248d2279.40860128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BB0EDF4-8CB8-4F06-AC76-14ACB156D804</gtr:id><gtr:title>SDM: a server for predicting effects of mutations on protein stability.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2740deeccb57d942289f664e528efd0"><gtr:id>a2740deeccb57d942289f664e528efd0</gtr:id><gtr:otherNames>Pandurangan AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a97ecaf90dab0.62921407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>597D211A-A18B-47D9-8FB7-2B7A3D8E6A79</gtr:id><gtr:title>Functional interactions between polypyrimidine tract binding protein and PRI peptide ligand containing proteins.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a005c6aa609d22b786ca11c79fda470"><gtr:id>9a005c6aa609d22b786ca11c79fda470</gtr:id><gtr:otherNames>Coelho MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5a35f95073b575.22979943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E2FC37B-0D43-4081-B2F8-9EB51B061EBC</gtr:id><gtr:title>TIBLE: a web-based, freely accessible resource for small-molecule binding data for mycobacterial species.</gtr:title><gtr:parentPublicationTitle>Database : the journal of biological databases and curation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dbdbde4ac8e3cf1a59a1e55e70fb328"><gtr:id>6dbdbde4ac8e3cf1a59a1e55e70fb328</gtr:id><gtr:otherNames>Malhotra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1758-0463</gtr:issn><gtr:outcomeId>5a97ecaee29295.86457989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>140DF53F-EF20-4BDC-AADC-AD6118F3E6AA</gtr:id><gtr:title>Decoding the similarities and differences among mycobacterial species.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dbdbde4ac8e3cf1a59a1e55e70fb328"><gtr:id>6dbdbde4ac8e3cf1a59a1e55e70fb328</gtr:id><gtr:otherNames>Malhotra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5a616d2c159903.28505228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E18FC80D-1C31-4FB6-BA34-98ED3510D46A</gtr:id><gtr:title>Targeting tuberculosis using structure-guided fragment-based drug design.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c71d23a1158640e848407ba21616708"><gtr:id>6c71d23a1158640e848407ba21616708</gtr:id><gtr:otherNames>Mendes V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>58be5dd8587d03.02313825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5E03EE8-6BA7-4D2A-91EF-4C37F3F0E190</gtr:id><gtr:title>pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>5a615ca9b87064.82249167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B9424FB-B1A5-474B-AE83-8218C87E8146</gtr:id><gtr:title>Fragment Screening against the EthR-DNA Interaction by Native Mass Spectrometry.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b1793c1a8fc1f05f8c3c0ecfa23db1e"><gtr:id>7b1793c1a8fc1f05f8c3c0ecfa23db1e</gtr:id><gtr:otherNames>Chan DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>5a97ecafc66c33.87873904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11E37B69-AE19-427E-964F-C651366476B0</gtr:id><gtr:title>Structure-guided, target-based drug discovery - exploiting genome information from HIV to mycobacterial infections.</gtr:title><gtr:parentPublicationTitle>Postepy biochemii</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dbdbde4ac8e3cf1a59a1e55e70fb328"><gtr:id>6dbdbde4ac8e3cf1a59a1e55e70fb328</gtr:id><gtr:otherNames>Malhotra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0032-5422</gtr:issn><gtr:outcomeId>58be5e4a6187e8.53309925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37D33AEA-5F95-4638-AC91-1FA6B3B2C635</gtr:id><gtr:title>The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.</gtr:title><gtr:parentPublicationTitle>ACS infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00d7673f8c199287b692989e5f71228e"><gtr:id>00d7673f8c199287b692989e5f71228e</gtr:id><gtr:otherNames>Singh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2373-8227</gtr:issn><gtr:outcomeId>58be5f3a03e9d5.94219452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989F0A86-DB97-426C-9953-440C57F4B281</gtr:id><gtr:title>Identifying Interactions that Determine Fragment Binding at Protein Hotspots.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c67d21e9dcc3c8006a4dd81be509c4f"><gtr:id>7c67d21e9dcc3c8006a4dd81be509c4f</gtr:id><gtr:otherNames>Radoux CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>58be5fbbe637d0.33512072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE39A738-1AB1-494E-BBFD-8F1D49F372C9</gtr:id><gtr:title>XSuLT: a web server for structural annotation and representation of sequence-structure alignments.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c3917cb62afa4a51fba21fa920370e"><gtr:id>13c3917cb62afa4a51fba21fa920370e</gtr:id><gtr:otherNames>Ochoa-Monta?o B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a97ecaf5e5cc9.08269472</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M026302/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>